{"pmid":32425320,"pmcid":"PMC7229475","title":"Nitrous oxide inhalant abuse and massive pulmonary embolism in COVID-19.","text":["Nitrous oxide inhalant abuse and massive pulmonary embolism in COVID-19.","A patient presented to the emergency department with altered mental status and lower extremity weakness in the setting of nitrous oxide inhalant abuse and Coronavirus Disease-2019 (COVID-19) infection. He subsequently developed hypotension and severe hypoxia, found to have a saddle pulmonary embolus (PE) with right heart strain requiring alteplase (tPA).","Am J Emerg Med","Molina, Melanie F","Al Saud, Ahad A","Al Mulhim, Abdullah A","Liteplo, Andrew S","Shokoohi, Hamid","32425320"],"abstract":["A patient presented to the emergency department with altered mental status and lower extremity weakness in the setting of nitrous oxide inhalant abuse and Coronavirus Disease-2019 (COVID-19) infection. He subsequently developed hypotension and severe hypoxia, found to have a saddle pulmonary embolus (PE) with right heart strain requiring alteplase (tPA)."],"journal":"Am J Emerg Med","authors":["Molina, Melanie F","Al Saud, Ahad A","Al Mulhim, Abdullah A","Liteplo, Andrew S","Shokoohi, Hamid"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425320","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.ajem.2020.05.023","e_drugs":["Nitrous Oxide"],"topics":["Case Report"],"weight":1,"_version_":1667252837733629953,"score":9.490897,"similar":[{"pmid":32313884,"pmcid":"PMC7164919","title":"COVID-19 complicated by Acute Pulmonary Embolism and Right-Sided Heart Failure.","text":["COVID-19 complicated by Acute Pulmonary Embolism and Right-Sided Heart Failure.","A patient with Coronavirus Disease-2019 (COVID-19) developed sudden shortness of breath and hypoxia. She was diagnosed with a massive pulmonary embolism (PE) complicated by right sided heart failure, which was successfully managed conservatively. This marks the first report of COVID-19 induced PE in association with acute heart failure.","JACC Case Rep","Ullah, Waqas","Saeed, Rehan","Sarwar, Usman","Patel, Rajesh","Fischman, David L","32313884"],"abstract":["A patient with Coronavirus Disease-2019 (COVID-19) developed sudden shortness of breath and hypoxia. She was diagnosed with a massive pulmonary embolism (PE) complicated by right sided heart failure, which was successfully managed conservatively. This marks the first report of COVID-19 induced PE in association with acute heart failure."],"journal":"JACC Case Rep","authors":["Ullah, Waqas","Saeed, Rehan","Sarwar, Usman","Patel, Rajesh","Fischman, David L"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32313884","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jaccas.2020.04.008","keywords":["covid-19","covid-19, coronavirus disease-2019","ekg, electrocardiogram","heart failure","pulmonary embolism","sars-cov-2, severe acute respiratory syndrome coronavirus-2","tte, transthoracic echocardiography"],"topics":["Case Report"],"weight":1,"_version_":1666138493513891840,"score":224.5321},{"pmid":32470156,"title":"The Novel Coronavirus Disease (COVID-19) Complicated by Pulmonary Embolism and Acute Respiratory Distress Syndrome.","text":["The Novel Coronavirus Disease (COVID-19) Complicated by Pulmonary Embolism and Acute Respiratory Distress Syndrome.","Acute respiratory distress syndrome and coagulopathy played an important role in morbidity and mortality of severe COVID-19 patients. A higher frequency of PE than expected in COVID-19 patients was recently reported. The presenting symptoms for PE were untypical including dyspnea, which is one of the major symptoms in severe COVID-19, especially in those patients with ARDS. We reported two COVID-19 cases with coexisting complications of PE and ARDS, aiming to consolidate the emerging knowledge of this global health emergency and raise the awareness that the hypoxemia or severe dyspnea in COVID-19 may be related to PE and not necessarily always due to the parenchymal disease. This article is protected by copyright. All rights reserved.","J Med Virol","Li, Ting","Cheng, Guang-Shing","Pipavath, Sudhakar","Kicska, Gregory","Liu, Liangjin","Kinahan, Paul E","Wu, Wei","32470156"],"abstract":["Acute respiratory distress syndrome and coagulopathy played an important role in morbidity and mortality of severe COVID-19 patients. A higher frequency of PE than expected in COVID-19 patients was recently reported. The presenting symptoms for PE were untypical including dyspnea, which is one of the major symptoms in severe COVID-19, especially in those patients with ARDS. We reported two COVID-19 cases with coexisting complications of PE and ARDS, aiming to consolidate the emerging knowledge of this global health emergency and raise the awareness that the hypoxemia or severe dyspnea in COVID-19 may be related to PE and not necessarily always due to the parenchymal disease. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Li, Ting","Cheng, Guang-Shing","Pipavath, Sudhakar","Kicska, Gregory","Liu, Liangjin","Kinahan, Paul E","Wu, Wei"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470156","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26068","keywords":["ards","covid-19","hypoxemia","pe"],"topics":["Case Report"],"weight":1,"_version_":1668420887192272896,"score":145.05386},{"pmid":32405161,"pmcid":"PMC7219417","title":"D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.","text":["D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.","Objective: To analyze the risk factors for pulmonary embolism (PE) in patients infected with COVID-19. Methods: We conducted an observational, retrospective study. Patients with severe infection with COVID-19 and suspected PE were included. Results: Patients with higher levels of D-dimer and those requiring intubation were at a higher risk of developing PE. Higher D-dimer levels were associated with a greater probability of PE 3, 6, 9 and 12 days after determining D-dimer levels with an OR of 1.7, 2.0, 2.4 and 2.4, respectively. Conclusion: In conclusion, patients infected with COVID-19 requiring OTI with higher levels of D-dimer have an increased risk of developing PE.","Respir Med","Garcia-Olive, Ignasi","Sintes, Helena","Radua, Joaquim","Capa, Jorge Abad","Rosell, Antoni","32405161"],"abstract":["Objective: To analyze the risk factors for pulmonary embolism (PE) in patients infected with COVID-19. Methods: We conducted an observational, retrospective study. Patients with severe infection with COVID-19 and suspected PE were included. Results: Patients with higher levels of D-dimer and those requiring intubation were at a higher risk of developing PE. Higher D-dimer levels were associated with a greater probability of PE 3, 6, 9 and 12 days after determining D-dimer levels with an OR of 1.7, 2.0, 2.4 and 2.4, respectively. Conclusion: In conclusion, patients infected with COVID-19 requiring OTI with higher levels of D-dimer have an increased risk of developing PE."],"journal":"Respir Med","authors":["Garcia-Olive, Ignasi","Sintes, Helena","Radua, Joaquim","Capa, Jorge Abad","Rosell, Antoni"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405161","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.rmed.2020.106023","keywords":["covid-19","d-dimer","pulmonary embolism"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666802845509222400,"score":143.10767},{"pmid":32454268,"title":"D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.","text":["D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.","OBJECTIVE: To analyze the risk factors for pulmonary embolism (PE) in patients infected with COVID-19. METHODS: We conducted an observational, retrospective study. Patients with severe infection with COVID-19 and suspected PE were included. RESULTS: Patients with higher levels of D-dimer and those requiring intubation were at a higher risk of developing PE. Higher D-dimer levels were associated with a greater probability of PE 3, 6, 9 and 12 days after determining D-dimer levels with an OR of 1.7, 2.0, 2.4 and 2.4, respectively. CONCLUSION: In conclusion, patients infected with COVID-19 requiring OTI with higher levels of D-dimer have an increased risk of developing PE.","Respir Med","Garcia-Olive, Ignasi","Sintes, Helena","Radua, Joaquim","Abad Capa, Jorge","Rosell, Antoni","32454268"],"abstract":["OBJECTIVE: To analyze the risk factors for pulmonary embolism (PE) in patients infected with COVID-19. METHODS: We conducted an observational, retrospective study. Patients with severe infection with COVID-19 and suspected PE were included. RESULTS: Patients with higher levels of D-dimer and those requiring intubation were at a higher risk of developing PE. Higher D-dimer levels were associated with a greater probability of PE 3, 6, 9 and 12 days after determining D-dimer levels with an OR of 1.7, 2.0, 2.4 and 2.4, respectively. CONCLUSION: In conclusion, patients infected with COVID-19 requiring OTI with higher levels of D-dimer have an increased risk of developing PE."],"journal":"Respir Med","authors":["Garcia-Olive, Ignasi","Sintes, Helena","Radua, Joaquim","Abad Capa, Jorge","Rosell, Antoni"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32454268","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.rmed.2020.106023","keywords":["covid-19","d-dimer","pulmonary embolism"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1667881798487506945,"score":143.10767},{"pmid":32348233,"title":"Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.","text":["Pulmonary Embolism and Increased Levels of d-Dimer in Patients with Coronavirus Disease.","We report 3 patients with coronavirus disease who had a decline in respiratory status during their hospital course that responded well to intravenous steroids and interleukin-6 receptor antagonist therapy. These patients later showed development of persistent hypoxia with increased levels of d-dimer levels and were given a diagnosis of pulmonary embolisms.","Emerg Infect Dis","Griffin, Daniel O","Jensen, Alexandra","Khan, Mushmoom","Chin, Jessica","Chin, Kelly","Saad, Jennifer","Parnell, Ryan","Awwad, Christopher","Patel, Darshan","32348233"],"abstract":["We report 3 patients with coronavirus disease who had a decline in respiratory status during their hospital course that responded well to intravenous steroids and interleukin-6 receptor antagonist therapy. These patients later showed development of persistent hypoxia with increased levels of d-dimer levels and were given a diagnosis of pulmonary embolisms."],"journal":"Emerg Infect Dis","authors":["Griffin, Daniel O","Jensen, Alexandra","Khan, Mushmoom","Chin, Jessica","Chin, Kelly","Saad, Jennifer","Parnell, Ryan","Awwad, Christopher","Patel, Darshan"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32348233","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.3201/eid2608.201477","keywords":["covid-19","sars-cov-2","coronavirus disease","d-dimer","deep vein thrombosis","hypercoagulability","prophylaxis","pulmonary embolism","respiratory infections","sequelae","severe acute respiratory syndrome coronavirus 2","thromboembolic","viruses"],"e_drugs":["Steroids"],"topics":["Case Report"],"weight":1,"_version_":1666138495448514560,"score":140.74533}]}